Veliparib + RT + TMZ in Patients With Unmethylated MGMT Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
A Randomized Phase II Trial of Veliparib, Radiotherapy and Temozolomide in Patients With Unmethylated MGMT Glioblastoma: The VERTU Study
Neuro-oncology 2021 May 13;[EPub Ahead of Print], HW Sim, KL McDonald, Z Lwin, EH Barnes, M Rosenthal, MC Foote, ES Koh, M Back, H Wheeler, EP Sulman, ME Buckland, L Fisher, R Leonard, M Hall, DM Ashley, S Yip, J Simes, M KhasrawFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.